Tag: EMA

spot_img

Hympavzi (marstacimab): New Treatment for Hemophilia

On 11 October 2024, Hympavzi (marstacimab-hncq), a human monoclonal antibody targeting “tissue factor pathway inhibitor” received US FDA’s approval as a new drug for...

Stay in touch:

87,515FansLike
41,881FollowersFollow
1,772FollowersFollow
49SubscribersSubscribe

Newsletter

Don't miss

Neanderthals Performed Dental Caries Interventions 59,000 Years Ago

Prehistoric dentistry is far older than 14,000 years as...

Brain-Computer Interfaces (BCI): Towards Humans’ Merger with AI 

The ongoing clinical trials of Brain-Computer Interfaces (BCIs) such...

Tumour Treating Fields (TTFields) approved for Pancreatic cancer

Cancer cells have electrically charged parts hence are influenced...

Scientific European invites Co-founder

Scientific European (SCIEU) invites you to join as a Co-Founder and investor, with both...

Future Circular Collider (FCC): CERN Council reviews Feasibility Study

The quest for the answers to the open questions (such as, which...